Literature DB >> 9702608

Caloric expenditure during cardiac rehabilitation.

J R Schairer1, T Kostelnik, S M Proffitt, K I Faitel, S Windeler, L B Rickman, C A Brawner, S J Keteyian.   

Abstract

PURPOSE: The purpose of this study was to describe estimated caloric expenditure among patients in a maintenance cardiac rehabilitation program relative to a stated goal of approximately 300 kcal/session or 1,000 kcal/week. Additionally, we assessed the validity of several different methods for estimating caloric expenditure.
METHODS: The caloric expenditure for an exercise session was evaluated in 30 of 65 patients exercising in a maintenance cardiac rehabilitation program. Patients exercised using a treadmill, dual-action ergometer, upright stepper, or reclining stepper. The kilocalorie expenditure was assessed by three different techniques. The first used liquid crystal display (LCD) readings from the equipment (LCD method), the second combined both the American College of Sports Medicine metabolic equations for treadmill walking and the LCD values from the other equipment (Combined method), and the third measured oxygen consumption (VO2 method).
RESULTS: The caloric expenditure for the LCD, Combined, and VO2 methods were 247 +/- 83, 245 +/- 80, and 230 +/- 88 kcal, respectively. Agreement between methods using intraclass correlation analysis was r = 0.84 (0.68 to 0.92, 95% confidence intervals) for LCD versus VO2 and r = 0.88 (0.77 to 0.94, 95% confidence intervals) for Combined versus VO2 method.
CONCLUSIONS: Most patients (83%) in a maintenance cardiac rehabilitation program exercise below 300 kcal per session, a level believed to be necessary to illicit favorable changes in cardiovascular health. Additionally, the Combined method provides a reasonable estimate of kilocalorie expenditure. Use of kilocalorie expenditure should be considered in the cardiac rehabilitation setting as a fourth component in the exercise prescription.

Entities:  

Mesh:

Year:  1998        PMID: 9702608     DOI: 10.1097/00008483-199807000-00006

Source DB:  PubMed          Journal:  J Cardiopulm Rehabil        ISSN: 0883-9212            Impact factor:   2.081


  7 in total

Review 1.  The treatment of obesity in cardiac rehabilitation.

Authors:  Philip A Ades; Patrick D Savage; Jean Harvey-Berino
Journal:  J Cardiopulm Rehabil Prev       Date:  2010 Sep-Oct       Impact factor: 2.081

Review 2.  How should we advise heart failure patients on exercise and what should we tell them?

Authors:  Ewa Piotrowicz; Piotr Orzechowski; Agnieszka Chrapowicka; Ryszard Piotrowicz
Journal:  Curr Heart Fail Rep       Date:  2014-09

Review 3.  The Treatment of Obesity in Cardiac Rehabilitation: A REVIEW AND PRACTICAL RECOMMENDATIONS.

Authors:  Philip A Ades; Patrick D Savage
Journal:  J Cardiopulm Rehabil Prev       Date:  2021-09-01       Impact factor: 3.646

4.  High-calorie-expenditure exercise: a new approach to cardiac rehabilitation for overweight coronary patients.

Authors:  Philip A Ades; Patrick D Savage; Michael J Toth; Jean Harvey-Berino; David J Schneider; Janice Y Bunn; Marie C Audelin; Maryann Ludlow
Journal:  Circulation       Date:  2009-05-11       Impact factor: 29.690

Review 5.  Contemporary Approaches to Prescribing Exercise in Coronary Artery Disease Patients.

Authors:  Peter H Brubaker; James H Ross; Kee Chan Joo
Journal:  Am J Lifestyle Med       Date:  2016-01-19

6.  Effect of continuous and interval exercise training on the PETCO2 response during a graded exercise test in patients with coronary artery disease.

Authors:  Enéas A Rocco; Danilo M L Prado; Alexandre G Silva; Jaqueline M A Lazzari; Pedro C Bortz; Débora F M Rocco; Carla G Rosa; Valter Furlan
Journal:  Clinics (Sao Paulo)       Date:  2012       Impact factor: 2.365

7.  Effects of community-based cardiac rehabilitation on body composition and physical function in individuals with stable coronary artery disease: 1.6-year followup.

Authors:  Sandra Mandic; Claire Hodge; Emily Stevens; Robert Walker; Edwin R Nye; Dianne Body; Leanne Barclay; Michael J A Williams
Journal:  Biomed Res Int       Date:  2013-07-07       Impact factor: 3.411

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.